Coronary Artery Bypass Graft (CABG) Market Size, Share, Growth, and Industry Analysis, By Type ( Saphenous Vein Grafts,Internal Thoracic Artery Grafts,Other Grafts ), By Application ( Medical Application,Others ), Regional Insights and Forecast to 2035

Coronary Artery Bypass Graft (CABG) Market Overview

Global Coronary Artery Bypass Graft (CABG) market size is anticipated to be worth USD 148.2 million in 2026, projected to reach USD 201.9 million by 2035 at a 3.5% CAGR.

The Coronary Artery Bypass Graft (CABG) Market represents a critical segment of the cardiovascular surgery industry, focusing on surgical procedures that restore blood flow to the heart by bypassing blocked coronary arteries. Globally, more than 1.1 million CABG procedures are performed annually across over 4,500 cardiac surgery centers, making it one of the most widely performed open-heart surgeries. The Coronary Artery Bypass Graft (CABG) Market Analysis indicates that approximately 72% of CABG procedures involve multi-vessel coronary artery disease cases, while nearly 28% involve single-vessel bypass operations.

The United States Coronary Artery Bypass Graft (CABG) Market accounts for a significant share of global cardiac surgical procedures, with more than 200,000 CABG surgeries performed annually across approximately 1,100 cardiac surgery hospitals. Coronary artery disease affects more than 18 million adults in the United States, and nearly 35% of patients with severe coronary artery blockages require surgical bypass procedures rather than catheter-based interventions. The Coronary Artery Bypass Graft (CABG) Market Research Report shows that about 82% of CABG surgeries in the United States involve triple or double bypass procedures, while single bypass surgeries represent nearly 18% of operations.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising prevalence of coronary artery disease contributes 61%, aging population accounts for 54%, increasing cardiovascular surgical procedures represent 48%, diabetes and obesity prevalence contribute 44%, and expansion of cardiac surgery hospitals influences 39% of Coronary Artery Bypass Graft (CABG) Market Growth drivers.
• Major Market Restraint: Percutaneous coronary intervention adoption impacts 46% of treatment decisions, high surgical risk concerns affect 33%, longer recovery periods influence 29%, hospital infrastructure limitations impact 27%, and shortage of cardiac surgeons affects 21% of Coronary Artery Bypass Graft (CABG) Market adoption.
• Emerging Trends: Off-pump CABG surgical techniques represent 27%, minimally invasive CABG procedures account for 32%, robotic-assisted cardiac surgery adoption contributes 21%, hybrid revascularization procedures represent 18%, and advanced intraoperative imaging technologies contribute 16% of Coronary Artery Bypass Graft (CABG) Market Trends.
• Regional Leadership: North America holds approximately 38% of the Coronary Artery Bypass Graft (CABG) Market Share, Europe represents 29%, Asia-Pacific accounts for 24%, and Middle East & Africa contribute nearly 9% of global Coronary Artery Bypass Graft (CABG) surgical procedures.
• Competitive Landscape: The top 8 cardiovascular device manufacturers control approximately 58% of the Coronary Artery Bypass Graft (CABG) Market Size, specialized cardiac surgical equipment providers represent 27%, regional medical device manufacturers contribute 10%, and niche cardiovascular technology firms account for 5%.
• Market Segmentation: Saphenous vein grafts represent 49% of Coronary Artery Bypass Graft (CABG) Market procedures, internal thoracic artery grafts account for 38%, other graft types represent 13%, medical surgical applications contribute 92%, and other clinical or research applications represent 8%.
• Recent Development: Robotic cardiac surgery technology integration represents 26% of innovations, advanced intraoperative graft imaging systems account for 23%, hybrid revascularization techniques represent 19%, improved graft preservation technologies contribute 17%, and AI-based surgical planning systems represent 11% of industry developments.

Coronary Artery Bypass Graft (CABG) Market Latest Trends

The Coronary Artery Bypass Graft (CABG) Market Trends reflect continuous advancements in cardiovascular surgery technologies, surgical techniques, and hospital cardiac care infrastructure. Globally, more than 1.1 million CABG surgeries are conducted each year, and approximately 72% of patients undergoing CABG procedures are over the age of 60, highlighting the influence of aging populations on Coronary Artery Bypass Graft (CABG) Market Growth. Modern CABG procedures often involve 2 to 4 bypass grafts per surgery, depending on the number of blocked coronary arteries requiring revascularization. One major trend in the Coronary Artery Bypass Graft (CABG) Industry Analysis is the increasing adoption of off-pump CABG procedures, which are performed without cardiopulmonary bypass machines.

Off-pump CABG procedures now account for nearly 27% of global CABG surgeries, reducing surgical complications such as neurological events and post-operative bleeding by approximately 15% to 20% compared with traditional on-pump techniques. Technological advancements in surgical imaging systems are also influencing the Coronary Artery Bypass Graft (CABG) Market Outlook. Intraoperative imaging systems capable of measuring graft blood flow rates exceeding 40 ml per minute allow surgeons to verify graft patency during surgery. Additionally, robotic-assisted cardiac surgery systems are increasingly used in minimally invasive CABG procedures performed through 4 cm to 6 cm surgical incisions, compared with traditional sternotomy incisions exceeding 20 cm. These technological innovations are improving surgical precision and reducing hospital recovery time from 10 days to approximately 6 days for certain minimally invasive procedures.

Coronary Artery Bypass Graft (CABG) Market Dynamics

The Coronary Artery Bypass Graft (CABG) Market Dynamics are influenced by the global prevalence of cardiovascular diseases, healthcare infrastructure expansion, surgical technology advancements, and the availability of specialized cardiac surgeons. More than 520 million people worldwide live with cardiovascular diseases, and coronary artery disease accounts for nearly 45% of all heart-related conditions, leading to over 1.1 million CABG procedures annually across approximately 4,500 cardiac surgery centers. Hospitals performing CABG surgeries typically conduct between 150 and 400 bypass procedures each year, requiring surgical teams of 4 to 6 cardiovascular specialists. However, the growth of alternative treatments such as percutaneous coronary intervention, which exceeds 4 million procedures annually, and the global shortage of nearly 35,000 practicing cardiac surgeons continue to influence the Coronary Artery Bypass Graft (CABG) Market Analysis.

DRIVER

"Increasing prevalence of coronary artery disease"

The rising prevalence of coronary artery disease represents one of the primary drivers of the Coronary Artery Bypass Graft (CABG) Market Growth. Cardiovascular diseases affect more than 520 million people globally, and coronary artery disease accounts for nearly 45% of all cardiovascular conditions. Each year, approximately 18 million deaths worldwide are associated with cardiovascular diseases, making it one of the leading causes of mortality globally. Coronary artery bypass graft surgery is commonly recommended for patients experiencing 70% or greater blockage in major coronary arteries, particularly in cases involving multi-vessel coronary artery disease. Hospitals performing CABG surgeries typically conduct 150 to 300 procedures annually, depending on the size of the cardiovascular surgery department. Additionally, the number of cardiac surgery centers worldwide has increased to more than 4,500 specialized cardiac hospitals, supporting expanding surgical capacity across the Coronary Artery Bypass Graft (CABG) Industry.

RESTRAINT

"Growing adoption of minimally invasive catheter procedures"

One of the primary restraints in the Coronary Artery Bypass Graft (CABG) Market is the increasing use of catheter-based coronary interventions such as percutaneous coronary intervention (PCI). Globally, more than 4 million PCI procedures are performed annually, representing a major alternative treatment for coronary artery disease. Approximately 55% of patients with single-vessel coronary artery disease undergo PCI rather than surgical bypass procedures. Catheter-based interventions typically involve smaller incisions measuring less than 5 mm, compared with CABG surgical incisions exceeding 20 cm in traditional sternotomy procedures. Additionally, PCI procedures often require hospital stays of only 1 to 2 days, compared with CABG recovery periods ranging from 7 to 10 days. These factors influence patient treatment decisions and impact the Coronary Artery Bypass Graft (CABG) Market Size in certain cardiovascular treatment segments.

OPPORTUNITY

"Advancements in robotic and minimally invasive cardiac surgery"

Technological innovations in robotic-assisted cardiac surgery present significant opportunities for the Coronary Artery Bypass Graft (CABG) Market Opportunities. Robotic surgical systems used in cardiovascular procedures allow surgeons to perform CABG operations through small thoracic incisions measuring 3 cm to 6 cm, significantly reducing surgical trauma compared with conventional open-heart procedures. More than 600 hospitals worldwide now operate robotic cardiac surgery systems capable of performing minimally invasive coronary bypass procedures. These systems offer enhanced surgical precision with robotic arms capable of movements with accuracy within 1 millimeter, improving graft placement accuracy during bypass surgery. Robotic-assisted CABG procedures also reduce patient recovery time by approximately 30%, enabling hospital discharge within 4 to 6 days compared with traditional procedures requiring recovery periods exceeding 9 days.

CHALLENGE

"Shortage of specialized cardiac surgeons"

One of the major challenges affecting the Coronary Artery Bypass Graft (CABG) Market is the global shortage of specialized cardiac surgeons. Cardiovascular surgery requires extensive medical training that typically includes 4 years of medical school, 5 years of general surgery residency, and 2 to 3 years of specialized cardiac surgery fellowship training, resulting in nearly 11 to 12 years of total medical education before surgeons can perform CABG procedures independently. Globally, there are approximately 35,000 practicing cardiac surgeons, which limits surgical capacity in many healthcare systems. Some countries have fewer than 1 cardiac surgeon per 500,000 people, creating access challenges for patients requiring bypass surgery. Additionally, hospitals performing complex CABG surgeries require advanced operating rooms equipped with cardiopulmonary bypass machines capable of circulating 4 to 6 liters of blood per minute, making infrastructure requirements another challenge within the Coronary Artery Bypass Graft (CABG) Industry.

Coronary Artery Bypass Graft (CABG) Market Segmentation

The Coronary Artery Bypass Graft (CABG) Market segmentation focuses on graft type and application areas used during coronary artery bypass surgeries performed in cardiac surgery centers worldwide. The Coronary Artery Bypass Graft (CABG) Market Analysis indicates that more than 1.1 million CABG procedures are performed annually across global cardiovascular hospitals, with each surgery requiring 1 to 4 grafts depending on the number of blocked coronary arteries. Segmentation within the Coronary Artery Bypass Graft (CABG) Market Size shows that saphenous vein grafts represent approximately 49% of procedures, internal thoracic artery grafts account for around 38%, while other graft types represent nearly 13% of surgical procedures. In terms of application, medical surgical applications represent approximately 92% of total CABG usage, while other clinical or research applications contribute around 8% of overall Coronary Artery Bypass Graft (CABG) Market Share across global cardiac surgery facilities.

Download Free Sample to learn more about this report.

By Type

Saphenous Vein Grafts: Saphenous vein grafts represent approximately 49% of the Coronary Artery Bypass Graft (CABG) Market Share, making them the most widely used graft type in CABG procedures worldwide. The saphenous vein is typically harvested from the patient’s leg and can measure between 30 cm and 45 cm in length, allowing surgeons to create multiple bypass grafts during a single procedure. In many CABG surgeries involving triple or quadruple bypass operations, saphenous vein grafts are used to bypass multiple blocked coronary arteries simultaneously. The Coronary Artery Bypass Graft (CABG) Industry Analysis indicates that more than 540,000 CABG procedures annually involve saphenous vein grafts globally. These grafts can support blood flow rates exceeding 80 ml per minute, providing adequate myocardial perfusion after surgery.

Internal Thoracic Artery Grafts: Internal thoracic artery grafts account for approximately 38% of the Coronary Artery Bypass Graft (CABG) Market Size, making them the second most common graft type used in CABG procedures. These grafts are typically harvested from the left or right internal thoracic artery, located along the inner chest wall, and are frequently used to bypass the left anterior descending coronary artery, which supplies nearly 45% of the heart’s blood flow. Internal thoracic artery grafts are known for their superior long-term durability, with patency rates exceeding 90% after 10 years, compared with approximately 60% for vein grafts. Approximately 420,000 CABG procedures annually involve internal thoracic artery grafts globally. These grafts are typically 20 cm to 25 cm long and are often used in single or double bypass surgeries where long-term graft survival is critical.

Other Grafts: Other graft types represent approximately 13% of the Coronary Artery Bypass Graft (CABG) Market Share, including radial artery grafts and synthetic graft materials used in specific clinical scenarios. Radial artery grafts are harvested from the patient’s forearm and typically measure between 18 cm and 22 cm in length, providing strong arterial blood flow suitable for bypassing moderately blocked coronary arteries. Approximately 140,000 CABG procedures annually involve radial artery grafts worldwide. Radial artery grafts demonstrate long-term patency rates of nearly 80% after 10 years, making them an effective alternative to saphenous vein grafts in selected cases. Synthetic graft materials, although less common, are sometimes used in specialized cardiovascular surgeries requiring vascular reconstruction.

By Application

Medical Application: Medical application represents approximately 92% of the Coronary Artery Bypass Graft (CABG) Market Share, as CABG procedures are primarily performed to treat coronary artery disease in patients experiencing severe arterial blockages. Coronary artery disease affects more than 200 million individuals globally, and approximately 7 million patients each year require advanced cardiovascular interventions such as bypass surgery or coronary stenting. CABG surgery is commonly recommended for patients with 70% to 90% blockage in multiple coronary arteries, particularly when drug therapies and catheter-based treatments are insufficient. Cardiac surgery centers performing CABG procedures typically conduct between 150 and 400 bypass surgeries annually, depending on hospital capacity. Each CABG surgery requires surgical teams consisting of 4 to 6 cardiovascular specialists, including surgeons, perfusionists, and anesthesiologists.

Other Applications: Other applications account for approximately 8% of the Coronary Artery Bypass Graft (CABG) Market Size, including research, surgical training programs, and experimental cardiovascular procedures conducted in academic medical centers. Medical research institutions perform approximately 4,000 to 6,000 experimental cardiovascular surgeries annually to study new graft materials, surgical techniques, and imaging technologies designed to improve CABG outcomes. Surgical training programs across more than 700 medical universities worldwide conduct CABG simulation procedures using synthetic graft models and advanced surgical training systems. These training programs typically involve 3 to 5 years of specialized cardiovascular surgical training for medical professionals learning advanced bypass techniques.

Regional Outlook for the Coronary Artery Bypass Graft (CABG) Market

The Coronary Artery Bypass Graft (CABG) Market Outlook shows significant regional differences in cardiovascular surgery adoption based on healthcare infrastructure, aging population demographics, and prevalence of coronary artery disease. Globally, more than 1.1 million CABG procedures are performed annually across more than 4,500 specialized cardiac surgery centers. Regional distribution within the Coronary Artery Bypass Graft (CABG) Market Share indicates that North America accounts for approximately 38% of global CABG surgeries, Europe represents around 29%, Asia-Pacific contributes nearly 24%, and Middle East & Africa collectively account for approximately 9% of global bypass surgery volumes. These regions operate thousands of cardiovascular surgery facilities equipped with advanced cardiac operating rooms capable of performing complex bypass procedures requiring 3 to 5 hours of surgical time per operation.

Download Free Sample to learn more about this report.

North America

North America holds approximately 38% of the global Coronary Artery Bypass Graft (CABG) Market Share, supported by advanced healthcare infrastructure and high prevalence of cardiovascular diseases. The region performs more than 420,000 CABG surgeries annually across approximately 1,500 cardiac surgery hospitals located in the United States and Canada. Coronary artery disease affects nearly 18 million adults in the United States alone, making cardiovascular interventions one of the most common hospital surgical procedures. North American cardiac surgery centers often operate 5 to 10 dedicated cardiac operating rooms and employ surgical teams capable of performing 200 to 400 CABG procedures annually per hospital. Advanced surgical imaging systems capable of measuring graft blood flow rates exceeding 40 ml per minute are widely used in these hospitals to verify graft performance during surgery.

Europe

Europe accounts for approximately 29% of the global Coronary Artery Bypass Graft (CABG) Market Size, supported by well-developed public healthcare systems and specialized cardiovascular treatment centers. The region performs more than 320,000 CABG surgeries annually across approximately 1,200 cardiac surgery hospitals. Countries such as Germany, France, Italy, and the United Kingdom collectively perform nearly 65% of European CABG procedures due to their large hospital networks and advanced cardiovascular research programs. European cardiac surgery departments often operate cardiopulmonary bypass machines capable of supporting blood circulation rates of 5 liters per minute, ensuring adequate oxygen supply during open-heart surgery. Approximately 68% of European CABG surgeries involve multi-vessel bypass procedures, requiring 2 to 4 grafts per patient.

Asia-Pacific

Asia-Pacific represents approximately 24% of the global Coronary Artery Bypass Graft (CABG) Market Share, driven by increasing cardiovascular disease prevalence and expanding healthcare infrastructure across countries such as China, India, Japan, and South Korea. The region performs more than 260,000 CABG procedures annually across approximately 1,100 cardiac surgery hospitals. Cardiovascular diseases affect more than 250 million individuals across Asia-Pacific, creating strong demand for surgical treatment options such as bypass surgery. Many hospitals in the region perform between 120 and 250 CABG surgeries annually, depending on hospital capacity and surgeon availability. Additionally, governments across several Asia-Pacific countries have invested in expanding cardiac surgery facilities, increasing the number of cardiovascular operating rooms capable of performing complex open-heart procedures.

Middle East & Africa

The Middle East & Africa region represents approximately 9% of the global Coronary Artery Bypass Graft (CABG) Market Share, with growing adoption of advanced cardiovascular surgical procedures across several countries. The region performs approximately 100,000 CABG surgeries annually across more than 700 cardiac surgery hospitals. Cardiovascular diseases account for nearly 40% of total deaths in several Middle Eastern countries, creating increasing demand for advanced cardiovascular treatments such as bypass surgery. Hospitals in countries such as Saudi Arabia, the United Arab Emirates, and South Africa operate specialized cardiac surgery departments capable of performing 150 to 250 CABG procedures annually.

List of Top Coronary Artery Bypass Graft (CABG) Companies

• Medtronic
• TERUMO
• Guidant
• MAQUET
• Vitalitec
• Novadaq Technologies
• KARL STORZ
• Edwards Lifesciences
• Genesee Biomedical

Medtronic: Medtronic holds approximately 16% of the global Coronary Artery Bypass Graft (CABG) Market Share, supported by a portfolio of cardiovascular surgical devices used in more than 4,000 cardiac surgery hospitals worldwide.

TERUMO: TERUMO accounts for nearly 13% of the Coronary Artery Bypass Graft (CABG) Market Size, providing cardiovascular surgical systems and cardiopulmonary bypass equipment used in approximately 1,500 cardiovascular surgery centers globally.

Investment Analysis and Opportunities

Investment in the Coronary Artery Bypass Graft (CABG) Market continues to increase as healthcare systems expand cardiovascular surgical infrastructure to treat the growing number of patients with coronary artery disease. Globally, more than 520 million people live with cardiovascular diseases, and approximately 18 million deaths annually are attributed to heart-related conditions, creating a strong demand for surgical interventions such as bypass procedures. Governments and healthcare institutions have invested in expanding cardiac surgery facilities, increasing the number of specialized cardiovascular operating rooms to more than 7,000 globally. Hospitals performing CABG surgeries typically invest in advanced surgical equipment including cardiopulmonary bypass machines capable of circulating 4 to 6 liters of blood per minute, surgical microscopes offering magnification levels of 10x to 20x, and intraoperative imaging systems capable of measuring graft blood flow rates exceeding 40 ml per minute.

Additionally, training programs for cardiovascular surgeons have expanded, with more than 700 medical institutions worldwide offering specialized cardiac surgery fellowship programs lasting 2 to 3 years. The Coronary Artery Bypass Graft (CABG) Market Opportunities are also expanding due to the development of minimally invasive surgical technologies and robotic-assisted cardiac surgery systems used in more than 600 hospitals worldwide. These technologies allow surgeons to perform bypass procedures through surgical incisions measuring 3 cm to 6 cm, reducing surgical trauma and improving patient recovery times by nearly 30%, strengthening the long-term Coronary Artery Bypass Graft (CABG) Market Outlook.

New Product Development

Innovation in the Coronary Artery Bypass Graft (CABG) Market is focused on improving surgical outcomes, enhancing graft durability, and developing advanced cardiovascular surgical technologies. Medical device manufacturers are introducing next-generation cardiopulmonary bypass machines capable of maintaining stable blood flow rates between 4 and 7 liters per minute, ensuring adequate oxygen delivery during complex cardiac surgeries. Modern bypass systems also include digital monitoring systems capable of measuring more than 25 physiological parameters including blood pressure, oxygen saturation, and temperature regulation during surgery. Another major area of innovation within the Coronary Artery Bypass Graft (CABG) Market Trends is the development of advanced graft imaging technologies. Intraoperative imaging systems capable of visualizing coronary blood flow using fluorescence imaging allow surgeons to verify graft patency immediately after placement.

These imaging systems can detect blood flow velocities exceeding 30 to 50 ml per minute, ensuring that bypass grafts are functioning correctly before the completion of surgery. Robotic-assisted cardiac surgery systems are also driving innovation in the Coronary Artery Bypass Graft (CABG) Industry Analysis. These systems use robotic arms capable of movement precision within 1 millimeter, allowing surgeons to perform delicate coronary artery suturing procedures through minimally invasive incisions. Currently, more than 600 hospitals worldwide operate robotic surgical systems capable of performing minimally invasive CABG procedures. These technologies reduce surgical incision size from traditional 20 cm sternotomy incisions to minimally invasive openings measuring 4 cm to 6 cm, significantly improving patient recovery times and surgical outcomes.

Five Recent Developments

• 2025 – Medtronic introduced an upgraded cardiopulmonary bypass monitoring system capable of tracking more than 30 surgical parameters simultaneously, improving intraoperative monitoring accuracy during CABG surgeries performed in more than 2,000 cardiac surgery centers worldwide.
• 2024 – TERUMO expanded its cardiovascular surgical technology portfolio by introducing advanced perfusion systems capable of maintaining blood circulation flow rates of 6 liters per minute, supporting complex bypass surgeries lasting up to 5 hours.
• 2024 – Edwards Lifesciences launched a next-generation intraoperative imaging system capable of detecting coronary graft blood flow exceeding 45 ml per minute, enabling surgeons to verify graft functionality immediately during bypass procedures.
• 2023 – KARL STORZ introduced a high-definition surgical imaging platform designed for minimally invasive cardiac surgery, offering visualization resolution exceeding 4K surgical imaging quality used in advanced cardiac operating rooms.
• 2023 – MAQUET developed a new cardiac stabilization system used during off-pump CABG procedures, enabling surgeons to perform bypass surgery without cardiopulmonary bypass support in nearly 27% of global CABG procedures.

Report Coverage of Coronary Artery Bypass Graft (CABG) Market

The Coronary Artery Bypass Graft (CABG) Market Report provides comprehensive analysis of global CABG surgical procedures, cardiovascular surgical technologies, graft types, and healthcare infrastructure supporting coronary artery bypass surgeries. The report evaluates more than 1.1 million CABG surgeries performed annually across approximately 4,500 cardiac surgery hospitals worldwide, providing detailed insights into surgical volumes and clinical adoption patterns. The Coronary Artery Bypass Graft (CABG) Market Research Report analyzes graft type segmentation including saphenous vein grafts representing 49% of procedures, internal thoracic artery grafts accounting for 38%, and other graft types representing 13% of global CABG surgeries. Application segmentation indicates that medical surgical applications account for approximately 92% of total CABG procedures, while other clinical and research applications represent nearly 8%.

Regional coverage within the Coronary Artery Bypass Graft (CABG) Industry Report includes analysis of cardiovascular surgical infrastructure across North America with 38% market share, Europe with 29%, Asia-Pacific with 24%, and Middle East & Africa with 9% of global CABG surgical procedures. The report also examines cardiac surgery centers performing between 150 and 400 bypass surgeries annually, operating rooms equipped with cardiopulmonary bypass machines capable of circulating 4 to 6 liters of blood per minute, and surgical teams consisting of 4 to 6 cardiovascular specialists. These insights provide detailed Coronary Artery Bypass Graft (CABG) Market Analysis, Coronary Artery Bypass Graft (CABG) Market Trends, Coronary Artery Bypass Graft (CABG) Market Opportunities, and Coronary Artery Bypass Graft (CABG) Market Outlook for healthcare providers, medical device manufacturers, and cardiovascular research organizations.